The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
P2 receptors, platelet function and pharmacological implications
Abstract
Summary: ADP and ATP play a crucial role in platelet activation and their receptors are potential targets for antithrombotic drugs. The ATP-gated cation channel P2X1 and the two G protein-coupled ADP receptors, P2Y1 and P2Y12, selectively contribute to platelet aggregation and formation of a thrombus.Owing to its central role in the growth and stabilization of a thrombus, the P2Y12 receptor is an established target of antithrombotic drugs like the thienopyridines clopidogrel or prasugrel, or competitive antag-onists such as cangrelor or AZD6140.The optimal inhibition of this receptor to reach clinical efficacy while preserving patients from unacceptable bleeding is a matter of debate. On the other hand, studies in P2Y1 and P2X1 knockout mice and using selective P2Y1 and P2X1 antagonists have shown that these receptors are also attractive targets for new antithrombotic compounds. Finally, the regulation by the P2 receptors of the platelet involvement in inflammatory processes is also briefly discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790 · cited 1×
“A large scale clinical trial, TRITON-TIMI 38, including 13,609 patients planned for percutaneous coronary intervention (PCI) upon assessment of coronary anatomy, 3/4 with unstable angina, 1/4 with myocardial infarction, has demonstrated the overall superiority of prasugrel (60-mg loading dose followed by 10-mg mainten…”
BackgroundAngiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276
Extracellular ATP: effects, sources and fate
Gordon, J. L. (1986) · Biochemical Journal · doi:10.1042/bj2330309 · Cited by 1,658
Gurbel, P. A., Bliden, K. P., Hiatt, B. L., & O’Connor, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000072771.11429.83 · Cited by 1,544
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542
Identification of the platelet ADP receptor targeted by antithrombotic drugs
Hollopeter, G., Jantzen, H.-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.-B., Nurden, P., Nurden, A., Julius, D., et al. (2001) · Nature · doi:10.1038/35051599 · Cited by 1,423
Hulot, J.-S. (2006) · Blood · doi:10.1182/blood-2006-04-013052 · Cited by 931
Purine and pyrimidine receptors
Burnstock, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6497-0 · Cited by 929
Wiviott, S. D., Trenk, D., Frelinger, A. L., O’Donoghue, M., Neumann, F.-J., Michelson, A. D., Angiolillo, D. J., Hod, H., Montalescot, G., Miller, D. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.740324 · Cited by 881
Variability in platelet responsiveness to clopidogrel among 544 individuals
Serebruany, V. L., Steinhubl, S. R., Berger, P. B., Malinin, A. I., Bhatt, D. L., & Topol, E. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.067 · Cited by 777
Identification and Biological Activity of the Active Metabolite of Clopidogrel
Savi, P., Pereillo, J. M., Uzabiaga, M. F., Combalbert, J., Picard, C., Maffrand, J. P., Pascal, M., & Herbert, J. M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614133 · Cited by 754
Husted, S., Emanuelsson, H., Heptinstall, S., Sandset, P. M., Wickens, M., & Peters, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi754 · Cited by 743
BRANDT, J. T., CLOSE, S. L., ITURRIA, S. J., PAYNE, C. D., FARID, N. A., ERNEST, C. S., LACHNO, D. R., SALAZAR, D., & WINTERS, K. J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02775.x · Cited by 734
Lau, W. C., Waskell, L. A., Watkins, P. B., Neer, C. J., Horowitz, K., Hopp, A. S., Tait, A. R., Carville, D. G. M., Guyer, K. E., & Bates, E. R. (2003) · Circulation · doi:10.1161/01.cir.0000047060.60595.cc · Cited by 688
Müller, I., Besta, F., Schulz, C., Massberg, S., Schönig, A., & Gawaz, M. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613462 · Cited by 585
PI 3-kinase p110β: a new target for antithrombotic therapy
Jackson, S. P., Schoenwaelder, S. M., Goncalves, I., Nesbitt, W. S., Yap, C. L., Wright, C. E., Kenche, V., Anderson, K. E., Dopheide, S. M., Yuan, Y., et al. (2005) · Nature Medicine · doi:10.1038/nm1232 · Cited by 580
Brandt, J. T., Payne, C. D., Wiviott, S. D., Weerakkody, G., Farid, N. A., Small, D. S., Jakubowski, J. A., Naganuma, H., & Winters, K. J. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.10.010 · Cited by 571
Jin, J., & Kunapuli, S. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8070 · Cited by 540
Resistance to clopidogrel: A review of the evidence
Nguyen, T. A., Diodati, J. G., & Pharand, C. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.034 · Cited by 520
Lau, W. C., Gurbel, P. A., Watkins, P. B., Neer, C. J., Hopp, A. S., Carville, D. G. M., Guyer, K. E., Tait, A. R., & Bates, E. R. (2004) · Circulation · doi:10.1161/01.cir.0000112378.09325.f9 · Cited by 487
Molecular Basis for ADP-induced Platelet Activation
Jin, J., Daniel, J. L., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2030 · Cited by 477
Léon, C., Hechler, B., Freund, M., Eckly, A., Vial, C., Ohlmann, P., Dierich, A., LeMeur, M., Cazenave, J.-P., & Gachet, C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8399 · Cited by 460
Self-citationFabre, J.-E., Nguyen, M., Latour, A., Keifer, J. A., Audoly, L. P., Coffman, T. M., & Koller, B. H. (1999) · Nature Medicine · doi:10.1038/13522 · Cited by 439
Snoep, J. D., Hovens, M. M. C., Eikenboom, J. C. J., van der Bom, J. G., Jukema, J. W., & Huisman, M. V. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.04.014 · Cited by 427
Fontana, P., Dupont, A., Gandrille, S., Bachelot-Loza, C., Reny, J.-L., Aiach, M., & Gaussem, P. (2003) · Circulation · doi:10.1161/01.cir.0000085073.69189.88 · Cited by 425
Foster, C. J., Prosser, D. M., Agans, J. M., Zhai, Y., Smith, M. D., Lachowicz, J. E., Zhang, F. L., Gustafson, E., Monsma, F. J., Wiekowski, M. T., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12242 · Cited by 415
Purinergic Signaling and Vascular Cell Proliferation and Death
Burnstock, G. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.105360 · Cited by 414
Scientific and therapeutic advances in antiplatelet therapy
Bhatt, D. L., & Topol, E. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd985 · Cited by 407
ALEIL, B., RAVANAT, C., CAZENAVE, J. P., ROCHOUX, G., HEITZ, A., & GACHET, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.01063.x · Cited by 402
Self-citationIndividual variations of platelet inhibition after loading doses of clopidogrel
Järemo, P., Lindahl, T. L., Fransson, S. G., & Richter, A. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01027.x · Cited by 327
Savi, P., & Herbert, J.-M. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-869523 · Cited by 327
Farid, N. A., Payne, C. D., Small, D. S., Winters, K. J., Ernest, C. S., Brandt, J. T., Darstein, C., Jakubowski, J. A., & Salazar, D. E. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100139 · Cited by 323
Savi, P., Zachayus, J.-L., Delesque-Touchard, N., Labouret, C., Hervé, C., Uzabiaga, M.-F., Pereillo, J.-M., Culouscou, J.-M., Bono, F., Ferrara, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510446103 · Cited by 317
REGULATION OF PLATELET FUNCTIONS BY P2 RECEPTORS
Gachet, C. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141207 · Cited by 295
Self-citationStorey, R. F., Sanderson, H. M., White, A. E., May, J. A., Cameron, K. E., & Heptinstall, S. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02208.x · Cited by 288
The P2Y1 Receptor Is Necessary for Adenosine 5′-Diphosphate–Induced Platelet Aggregation
Hechler, B., Léon, C., Vial, C., Vigne, P., Frelin, C., Cazenave, J.-P., & Gachet, C. (1998) · Blood · doi:10.1182/blood.v92.1.152.413k27_152_159 · Cited by 265
Self-citationHermann, A., Rauch, B. H., Braun, M., Schrör, K., & Weber, A.-A. (2001) · Platelets · doi:10.1080/09537100020031207 · Cited by 255
Preclinical and Clinical Studies with Selective Reversible Direct P2Y12Antagonists
van Giezen, J. J. J., & Humphries, R. G. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-869525 · Cited by 251
Niitsu, Y., Jakubowski, J. A., Sugidachi, A., & Asai, F. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-869524 · Cited by 236
SUGIDACHI, A., OGAWA, T., KURIHARA, A., HAGIHARA, K., JAKUBOWSKI, J. A., HASHIMOTO, M., NIITSU, Y., & ASAI, F. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02598.x · Cited by 220
A Role of the Fast ATP-gated P2X1 Cation Channel in Thrombosis of Small Arteries In Vivo
Hechler, B., Lenain, N., Marchese, P., Vial, C., Heim, V., Freund, M., Cazenave, J.-P., Cattaneo, M., Ruggeri, Z. M., Evans, R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030144 · Cited by 220
Self-citationGeiger, J., Brich, J., Hönig-Liedl, P., Eigenthaler, M., Schanzenbächer, P., Herbert, J. M., & Walter, U. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.8.2007 · Cited by 212
Role of P2Y1 purinoceptor in ADP‐induced platelet activation
Savi, P., Beauverger, P., Labouret, C., Delfaud, M., Salel, V, Kaghad, M., & Herbert, J. M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00025-8 · Cited by 197
Oldroyd, K., Wilcox, R., Storey, R., & the Investigators (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615596 · Cited by 194
Activation of Rap1B by Gi Family Members in Platelets
Woulfe, D., Jiang, H., Mortensen, R., Yang, J., & Brass, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202212200 · Cited by 192
Wihlborg, A.-K., Wang, L., Braun, O. O., Eyjolfsson, A., Gustafsson, R., Gudbjartsson, T., & Erlinge, D. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000142376.30582.ed · Cited by 188
Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection
CATTANEO, M. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02498.x · Cited by 179
Intensifying Platelet Inhibition — Navigating between Scylla and Charybdis
Bhatt, D. L. (2007) · New England Journal of Medicine · doi:10.1056/nejme0706859 · Cited by 179
Monitoring of Clopidogrel Action: Comparison of Methods
Geiger, J., Teichmann, L., Grossmann, R., Aktas, B., Steigerwald, U., Walter, U., & Schinzel, R. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.047050 · Cited by 179
P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms
Hardy, A. R., Conley, P. B., Luo, J., Benovic, J. L., Poole, A. W., & Mundell, S. J. (2005) · Blood · doi:10.1182/blood-2004-07-2893 · Cited by 176
P2Y 12 H2 Haplotype Is Associated With Peripheral Arterial Disease: A Case-Control Study
Fontana, P., Gaussem, P., Aiach, M., Fiessinger, J.-N., Emmerich, J., & Reny, J.-L. (2003) · Circulation · doi:10.1161/01.cir.0000106904.80795.35 · Cited by 164
Differential Involvement of the P2Y 1 and P2Y 12 Receptors in Platelet Procoagulant Activity
Léon, C., Ravanat, C., Freund, M., Cazenave, J., & Gachet, C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000092127.16125.e6 · Cited by 147
Self-citationPlatelet ADP receptors contribute to the initiation of intravascular coagulation
Léon, C., Alex, M., Klocke, A., Morgenstern, E., Moosbauer, C., Eckly, A. E., Spannagl, M., Gachet, C., & Engelmann, B. (2003) · Blood · doi:10.1182/blood-2003-05-1385 · Cited by 143
Self-citationLéon, C., Freund, M., Ravanat, C., Baurand, A., Cazenave, J., & Gachet, C. (2001) · Circulation · doi:10.1161/01.cir.103.5.718 · Cited by 139
Self-citationHechler, B., Eckly, A. E., Ohlmann, P., Cazenave, J., & Gachet, C. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01056.x · Cited by 139
Self-citationOury, C., Kuijpers, M. J. E., Tóth-Zsámboki, E., Bonnefoy, A., Danloy, S., Vreys, I., Feijge, M. A. H., Vos, R. D., Vermylen, J., Heemskerk, J. W. M., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3215 · Cited by 139
Storey, R. F., Wilcox, R. G., & Heptinstall, S. (2002) · Platelets · doi:10.1080/0953710021000024402 · Cited by 138
Steinhubl, S. R., Badimón, J. J., Bhatt, D. L., Herbert, J., & Lüscher, T. F. (2007) · Vascular Medicine · doi:10.1177/1358863x07077462 · Cited by 134
P2 receptors: new potential players in atherosclerosis
Virgilio, F. D., & Solini, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704524 · Cited by 132
Disordered Cellular Migration and Angiogenesis in cd39- Null Mice
Goepfert, C., Sundberg, C., Sévigny, J., Enjyoji, K., Hoshi, T., Csizmadia, E., & Robson, S. C. (2001) · Circulation · doi:10.1161/hc5001.100663 · Cited by 132
Lenain, N., Freund, M., Léon, C., Cazenave, J., & Gachet, C. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00144.x · Cited by 119
Self-citationAspirin resistance and a single gene
Jefferson, B. K., Foster, J. H., McCarthy, J. J., Ginsburg, G. S., Parker, A. N., Kottke‐Marchant, K., & Topol, E. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.11.045 · Cited by 112
Lotrionte, M., Biondi‐Zoccai, G., Agostoni, P., Abbate, A., Angiolillo, D. J., Valgimigli, M., Moretti, C., Meliga, E., Cuisset, T., Alessi, M., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.05.048 · Cited by 112
The platelet P2 receptors as molecular targets for old and new antiplatelet drugs
Gachet, C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.009 · Cited by 106
Self-citationKassack, M. U., Braun, K., Ganso, M., Ullmann, H., Nickel, P., Böing, B., Müller, G. M., & Lambrecht, G. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.01.007 · Cited by 106
Hechler, B., Magnenat, S., Zighetti, M. L., Kassack, M. U., Ullmann, H., Cazenave, J., Evans, R. J., Cattaneo, M., & Gachet, C. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084673 · Cited by 96
Self-citationPlatelet P2 receptors: old and new targets for antithrombotic drugs
Cattaneo, M. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.1.45 · Cited by 90
Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis
Conley, P. B., & Delaney, S. M. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200309000-00002 · Cited by 76
Emerging roles for P2X1receptors in platelet activation
Mahaut‐Smith, M. P., Tolhurst, G., & Evans, R. J. (2004) · Platelets · doi:10.1080/09537100410001682788 · Cited by 74
Jacobsson, F., Swahn, E., Wallentin, L. C., & Dellborg, M. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85149-9 · Cited by 74
Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease
Cavallari, U., Trabetti, E., Malerba, G., Biscuola, M., Girelli, D., Olivieri, O., Martinelli, N., Angiolillo, D. J., Corrocher, R., & Pignatti, P. F. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-59 · Cited by 70
Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model
Li, M., Zhang, Y., Ren, H., Zhang, Y., & Zhu, X. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.006 · Cited by 57
Angiolillo, D. J. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707060-00005 · Cited by 56
Cited by
Collet, J.-P., Hulot, J.-S., Pena, A., Villard, E., Esteve, J.-B., Silvain, J., Payot, L., Brugier, D., Cayla, G., Beygui, F., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61845-0 · Cited by 967
Signaling at Purinergic P2X Receptors
Surprenant, A., & North, R. A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100630 · Cited by 547
Platelet receptors and signaling in the dynamics of thrombus formation
Rivera, J., Lozano, M. L., Navarro-Nunez, L., & Vicente, V. (2009) · Haematologica · doi:10.3324/haematol.2008.003178 · Cited by 416
Two disparate ligand-binding sites in the human P2Y1 receptor
Zhang, D., Gao, Z.-G., Zhang, K., Kiselev, E., Crane, S., Wang, J., Paoletta, S., Yi, C., Ma, L., Zhang, W., et al. (2015) · Nature · doi:10.1038/nature14287 · Cited by 365
Purinergic Signaling and Blood Vessels in Health and Disease
Burnstock, G., & Ralevic, V. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008029 · Cited by 303
Metadata
- Authors
- Gachet, C.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2008
- Volume
- 99
- Issue
- 03
- Pages
- 466-472
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2093248288
- Cited by
- 297
- References
- 75
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.